NPHS2 mutation (431C>A) in a nephrotic patient with focal and segmental glomerulonephrosis

Wei ZHOU,Nan CHEN,Xiaoxia PAN,Xiaonong CHEN,Hong REN,Zhaohui WANG,Yongrui WU,Ying LU
DOI: https://doi.org/10.3969/j.issn.1006-298X.2005.02.006
2005-01-01
Abstract:Objective: Studies of genetic background for refractory nephrotic syndrome have associated genes encoding proteins in slit membrane of podocyte foot processes with differe nt types of familial and sporadic glomerulopathies. Mutations of NPHS2 gene, e ncoding podocin, have been demonstrated by various studies to be responsible f or sporadic steroid-resistant nephrotic syndrome. In this study, we studied NP HS2 mutation in Chinese patients with sporadic refractory nephrotic syndrome, a nd discovered a noval mutation of NPHS2 (431CA) in a Chinese with focal and seg mental glomerulosclerosis(FSGS). Methodology:Genomic DNA extracted from pheripheral blood cells was amplified by PCR, and mut ations of NPHS2 was analyzed by direct DNA sequencing. Nineteen patients with sp oradic refractory nephritic syndrome were included in this study, with 15 males and 4 females, aged between 4 and 48 years. All of them were hospitalized betwee n 1997 and 2004. 17 of the 19 patients underwent a renal biopsy for pathologic c lassification. Among them, 7 were grouped as steroid-insensitive (5 classified as FSGS, 1 as minimal change disease, and 1 as mesangial proliferative glomerulo nephritis), and 12 grouped as steroid-dependent (6 classified as minimal change disease, 4 as FSGS, 2 unclassified). 51 healthy subject were included in the c ontrol group. Results:A novel NPHS2 heterozygous mutation ( 431CA), causing the 144th amino acid prol ine to be substituted by histidine, was detected in a patient with FSGS grouped as steroid-dependent. No such mutation was detected in any of the control group . Eleven SNPs were detected in this group of patients, including 3 located in ex on, 4 in inexon, 1 in the promoter region, 1 in 5-UTR, and 2 in 3-UTR. Imm unofluescence staining of biopsy slides with monoantibody to podocin revealed th at a significant decreament of expression of podocin in glomerular region in all the patients. Conclusion:In this study, we reported a novel NPHS2 heterozygous mutation in a FSGS patient who is steroid dependent. And, we found significant decrement of podocin expres sion in all patients with sporadic refractory nephrotic syndrome.
What problem does this paper attempt to address?